Magnetic Resonance Imaging (MRI)
21
5
7
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 21 trials
100.0%
+13.5% vs benchmark
10%
2 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (21)
Cervical Lordosis: Imaging Position and Measurement
PASTRAMI : Patient-specific Statistics for Microstructure-augmented Connectomics
Carbon Dioxide Administration and Brain Waste Clearance
New Simulation Care Pathway for Paediatric MRI Preparation
MRI-Based Estimation of Lumbar CSF Volume and Its Clinical Impact on Spinal Anaesthesia
7.0 Tesla Resonance Magnetic Imaging of the Hand in Systemic Sclerosis
Internet-Based Cognitive Behavioral Therapy for MRI-Related Anxiety
MRI Assessment of Patient Suitability for Cardiac Resynchronization Therapy (CRT)
Interest of Magnetic Resonance Imaging in the Diagnosis of Upper Urinary Tract Invasive Tumours
Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension
Using Cardiac MRI to Predict Outcomes in Patients With STEMI
Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk
Maternal Cardiovascular Adaption to Pregnancy in IVF Patients Following Frozen Embryo Transfer (FET)
Effect of Brain GABA Metabolite Amount to Propofol Utilisation Under TIVA in Hypothyroid Patient
Multimodal Image Technologies Investigate the Role and Mechanism of Probiotics in Improving RBD with Parkinson's Disease
Neurologic Evaluation of Patients After Transapical Beating-Heart Septal Myectomy
Efficacy of Immersive Entertainement Glasses in Magnetic Resonance Imaging (MRI)
Myocardial Injury in Patients With Cardiac Implantable Electronic Devices Following Magnetic Resonance Imaging
Post-marketing Safety Study in Participants of All Pathologies Who Receive Gadolinium-Based Contrast Agents (GBCAs) for Contrast-Enhanced Magnetic Resonance Imaging (MR) Examination
Evaluation of Approved Pacing Lead (Model 5076) for Use in MRI Environment